002821 凯莱英
已收盘 08-23 15:00:00
资讯
新帖
简况
凯莱英(06821)：5.754万股限售股将于8月27日起上市流通
智通财经 · 08-23 22:33
凯莱英(06821)：5.754万股限售股将于8月27日起上市流通
CXO板块震荡！美迪西首次出现亏损，药明康德、康龙化成、凯莱英连续大跌
医药经济报 · 08-21
CXO板块震荡！美迪西首次出现亏损，药明康德、康龙化成、凯莱英连续大跌
港股异动 | 凯莱英(06821)跌超4%领跌CRO概念 行业受医药行业投融资下滑影响业绩普遍承压
智通财经 · 08-21
港股异动 | 凯莱英(06821)跌超4%领跌CRO概念 行业受医药行业投融资下滑影响业绩普遍承压
凯莱英(06821)下跌5.21%，报40.9元/股
金融界 · 08-20
凯莱英(06821)下跌5.21%，报40.9元/股
凯莱英(06821)拟回购注销1680股A股限制性股票
智通财经 · 08-16
凯莱英(06821)拟回购注销1680股A股限制性股票
凯莱英(06821)购回及注销根据2020年受限制A股股权激励计划授予的1680股受限制A股
智通财经 · 08-16
凯莱英(06821)购回及注销根据2020年受限制A股股权激励计划授予的1680股受限制A股
凯莱英完成购回及注销合共175.34万股受限制A股
新浪港股 · 08-15
凯莱英完成购回及注销合共175.34万股受限制A股
凯莱英(06821)完成购回及注销合共175.34万股受限制A股
智通财经 · 08-14
凯莱英(06821)完成购回及注销合共175.34万股受限制A股
凯莱英(06821)8月14日斥资2.25亿元回购175.34万股A股
智通财经网 · 08-14
凯莱英(06821)8月14日斥资2.25亿元回购175.34万股A股
摩根大通减持凯莱英(06821)16.23万股 每股作价约47.84港元
智通财经 · 08-13
摩根大通减持凯莱英(06821)16.23万股 每股作价约47.84港元
凯莱英（002821）8月9日主力资金净卖出6999.55万元
证券之星 · 08-12
凯莱英（002821）8月9日主力资金净卖出6999.55万元
凯莱英(06821.HK)累计回购1,230万股A股 涉资10亿人民币
阿斯达克财经 · 08-01
凯莱英(06821.HK)累计回购1,230万股A股 涉资10亿人民币
【凯莱英(06821.HK)截至7月末累计回购公司A股股份数量为1230.07万股】智通财经APP讯，凯莱英(06821.
智通财经 · 08-01
【凯莱英(06821.HK)截至7月末累计回购公司A股股份数量为1230.07万股】智通财经APP讯，凯莱英(06821.
凯莱英(002821.SZ)已累计回购3.5976%股份 耗资约10亿元
智通财经 · 08-01
凯莱英(002821.SZ)已累计回购3.5976%股份 耗资约10亿元
凯莱英：尊敬的投资，有关公司各成熟和新兴业务板块经营情况已在定期报告中进行过详细披露
证券之星 · 07-31
凯莱英：尊敬的投资，有关公司各成熟和新兴业务板块经营情况已在定期报告中进行过详细披露
凯莱英(06821)上涨5.19%，报46.65元/股
金融界 · 07-31
凯莱英(06821)上涨5.19%，报46.65元/股
【港股异动 | CRO概念股早盘走高 药明康德季度净利润环比增长 康龙化成新签订单金额实现两位数增长】智通财经APP获悉，CRO概念股早盘走高，截至发稿，药明生物(02269.
智通财经 · 07-31
【港股异动 | CRO概念股早盘走高 药明康德季度净利润环比增长 康龙化成新签订单金额实现两位数增长】智通财经APP获悉，CRO概念股早盘走高，截至发稿，药明生物(02269.
【港股异动 | CRO概念股多数走高 药明康德(02359.HK)上半年业绩符合预期 在手订单首超400亿】智通财经APP获悉，CRO概念股多数走高，截至发稿，药明康德(02359.
智通财经 · 07-30
【港股异动 | CRO概念股多数走高 药明康德(02359.HK)上半年业绩符合预期 在手订单首超400亿】智通财经APP获悉，CRO概念股多数走高，截至发稿，药明康德(02359.
摩根大通减持凯莱英(06821)约17.61万股 每股作价约44.75港元
智通财经网 · 07-29
摩根大通减持凯莱英(06821)约17.61万股 每股作价约44.75港元
凯莱英（002821）7月26日主力资金净卖出202.82万元
证券之星 · 07-29
凯莱英（002821）7月26日主力资金净卖出202.82万元
暂无数据
公司概况
公司名称：
凯莱英医药集团(天津)股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
凯莱英医药集团(天津)股份有限公司是一家全球领先的服务于新药研发和生产的CDMO一站式综合服务商。为国内外大中型制药企业、生物技术公司提供高效和高质量的研发与生产服务，助推创新药的临床研究与商业化应用。主要包括临床阶段药品、商业化阶段药品、技术服务。公司是全球第五大创新药原料药CDMO公司，约占据1.5%的市场份额（第一名市场份额约为2.9%）；是中国最大的商业化阶段化学药物CDMO公司，约占据22%的市场份额。
发行价格：
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":60.13,"timestamp":1724396622000,"preClose":61.23,"halted":0,"volume":2988442,"delay":0,"floatShares":329000000,"shares":368000000,"eps":5.2226,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.1,"latestTime":"08-23 15:00:00","open":61.04,"high":61.49,"low":59.9,"amount":180000000,"amplitude":0.026,"askPrice":60.14,"askSize":20,"bidPrice":60.13,"bidSize":24,"shortable":0,"etf":0,"ttmEps":5.2226,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":61.23,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":67.35,"lowLimit":55.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":367718103,"pbRate":1.28,"roa":"--","roe":"1.6%","epsLYR":6.26,"committee":0.580756,"marketValue":22111000000,"floatMarketCap":19758000000,"peRate":11.513422,"changeRate":-0.018,"turnoverRate":0.0091,"status":1},"requestUrl":"/m/hq/s/002821/tweets","defaultTab":"tweets","newsList":[{"id":"2461518791","title":"凯莱英(06821)：5.754万股限售股将于8月27日起上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2461518791","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461518791?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:33","pubTimestamp":1724423614,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)公布，本次解除 2020 年限制性股票激励计划预留授予部分第三次解除限售的限售股票数量为 57,540 股，占公司 A 股总股本 0.0169%，涉及股东人数 29 人;上市流通日期为2024 年 8 月 27 日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","002821","BK1191","BK0132","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2461211068","title":"CXO板块震荡！美迪西首次出现亏损，药明康德、康龙化成、凯莱英连续大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2461211068","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461211068?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:43","pubTimestamp":1724247802,"startTime":"0","endTime":"0","summary":"在股价方面，包括药明康德、康龙化成、凯莱英等在内的头部CXO企业，均遭遇到资本市场下行压力，向产业链上游传导的“价格战”正在引发股价、市值呈现连续下跌。作为中国CXO行业的领军企业，药明康德近期发布了其2024年半年报业绩，引起了市场的广泛关注。这一数据进一步证明了药明康德在行业中的领先地位和持续的发展潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082122064395afdb1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082122064395afdb1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","BK0239","LU1997245177.USD","LU0456842615.SGD","002821","LU1328615791.USD","03759","300759","688202","603259","02359","BK0132","LU1997245094.SGD","06821","LU2488822045.USD"],"gpt_icon":0},{"id":"2461181862","title":"港股异动 | 凯莱英(06821)跌超4%领跌CRO概念 行业受医药行业投融资下滑影响业绩普遍承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2461181862","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461181862?lang=zh_cn&edition=full","pubTime":"2024-08-21 15:22","pubTimestamp":1724224975,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股今日普跌，截至发稿，凯莱英跌3.74%，报39.9港元；泰格医药跌3.67%，报30.2港元；康龙化成跌3.06%，报8.55港元；药明康德跌2.88%，报32.05港元。海外临床CRO需求虽继续增长，但部分临床CRO公司的订单增速放缓，未来增长可能承压。海外临床前CRO仍面临需求压力，仍需等待宏观环境转好带来的订单复苏信号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1167566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","002821","BK0132","LU2045819591.USD","BK1583","LU1046422090.SGD","BK0239","03347","LU0708995583.HKD","BK1576","LU2242644610.SGD","LU1328615791.USD","LU0052750758.USD","LU2125910500.SGD","02359","BK1191","BK1141","03759","LU0320764599.SGD"],"gpt_icon":0},{"id":"2460424025","title":"凯莱英(06821)下跌5.21%，报40.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2460424025","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460424025?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:37","pubTimestamp":1724139460,"startTime":"0","endTime":"0","summary":"8月20日，凯莱英(06821)盘中下跌5.21%，截至15:37，报40.9元/股，成交1116.29万元。凯莱英医药集团是一家全球领先的CDMO公司，主要为全球新药提供从临床早期到商业化阶段的一站式研发、生产服务，包括高级中间体、原料药、制剂的研发和cGMP生产，以及临床研究服务。公司通过持续技术创新和战略合作，为国内外制药公司、生物技术公司提供药品全生命周期一站式CMC服务，加快新药开发及应用，逐步构建起创新药一体化服务生态圈。截至2024年一季报，凯莱英营业总收入13.64亿元、净利润2.82亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/20153742516510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0132","002821","06821","BK0239","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2459700211","title":"凯莱英(06821)拟回购注销1680股A股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2459700211","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459700211?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:04","pubTimestamp":1723813499,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，公司于2024年8月16日召开第四届董事会第五十五次会议审议通过了《关于回购注销2020年限制性股票激励计划部分限制性股票的议案》，同意对预留授予1名离职激励对象孙学惠已授予但尚未解除限售的1680股A股限制性股票进行回购注销的处理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","159982","06821","LU1328615791.USD","BK0132","399300","BK0239","002821"],"gpt_icon":0},{"id":"2459160052","title":"凯莱英(06821)购回及注销根据2020年受限制A股股权激励计划授予的1680股受限制A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459160052","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459160052?lang=zh_cn&edition=full","pubTime":"2024-08-16 20:43","pubTimestamp":1723812236,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2024年8月16日，公司董事会审议并通过《关于回购注销2020年限制性股票激励计划部分限制性股票的议案》，据此将购回及注销1680股由一名已离职合资格参与者根据2020年受限制A股股权激励计划预留授予项下所持有的已授出但尚未解禁的受限制A股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","159982","06821","LU1328615791.USD","BK0132","399300","BK0239","002821"],"gpt_icon":0},{"id":"2459558694","title":"凯莱英完成购回及注销合共175.34万股受限制A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459558694","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459558694?lang=zh_cn&edition=full","pubTime":"2024-08-15 07:44","pubTimestamp":1723679040,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 凯莱英（06821）发布公告，截至本公告日期，已完成购回及注销合共175.34万股受限制A股股份。公司已发行股本已由3.69亿股股份（包括3.42亿股A股及27553260股H股）减少至3.68亿股股份（包括3.4亿股A股及2755.33万股H股）。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-15/doc-incisrnk1821628.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-15/doc-incisrnk1821628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06821","BK0239","BK1191","LU1328615791.USD","002821","159982","BK0132","399300"],"gpt_icon":0},{"id":"2459173946","title":"凯莱英(06821)完成购回及注销合共175.34万股受限制A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459173946","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459173946?lang=zh_cn&edition=full","pubTime":"2024-08-14 20:28","pubTimestamp":1723638537,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，截至本公告日期，已完成购回及注销合共175.34万股受限制A股股份。公司已发行股本已由3.69亿股股份(包括3.42亿股A股及27553260股H股)减少至3.68亿股股份(包括3.4亿股A股及2755.33万股H股)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","399300","06821","BK1191","002821","LU1328615791.USD","BK0239","159982"],"gpt_icon":0},{"id":"2459786901","title":"凯莱英(06821)8月14日斥资2.25亿元回购175.34万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459786901","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459786901?lang=zh_cn&edition=full","pubTime":"2024-08-14 20:11","pubTimestamp":1723637502,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2024年8月14日，该公司斥资2.25亿元回购175.34万股A股。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159982","BK0132","BK1191","06821","LU1328615791.USD","002821","BK0239","399300"],"gpt_icon":0},{"id":"2459978406","title":"摩根大通减持凯莱英(06821)16.23万股 每股作价约47.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459978406","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459978406?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:05","pubTimestamp":1723543519,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月7日，摩根大通减持凯莱英(06821)16.23万股，每股作价47.8356港元，总金额约为776.37万港元。减持后最新持股数目为157.3803万股，持股比例为5.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B775SV38.USD","IE00BLSP4239.USD","IE00BKVL7J92.USD","BK4566","IE00BLSP4452.SGD","BK4516","LU0211326839.USD","LU1244550221.USD","LU1670628061.USD","LU0211328371.USD","BK4585","IE000M9KFDE8.USD","BK4533","IE00BHPRN162.USD","LU1894683348.USD","LU0211331839.USD","LU0211326755.USD","IE00B1BXHZ80.USD","LU1244550577.SGD","002821","IE00BJTD4N35.SGD","LU1668664300.SGD","LU0149725797.USD","LU0267386448.USD","LU0320765646.SGD","LU0971096721.USD","IE00B3S45H60.SGD","LU1261432733.SGD","LU0208291251.USD","06821","LU0496365809.HKD","BK0132","LU0256863811.USD","IE00BBT3K403.USD","LU1496350171.SGD","LU1894683264.USD","BK4534","LU0310799852.SGD","IE0034235188.USD","LU0211327993.USD","LU","LU0106831901.USD","BK0239","IE00BFXG1179.USD","IE00B1XK9C88.USD","LU1363072403.SGD","BK4207","IE00BZ1G4Q59.USD","IE00BJTD4V19.USD","BK4550"],"gpt_icon":0},{"id":"2458648726","title":"凯莱英（002821）8月9日主力资金净卖出6999.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458648726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458648726?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:22","pubTimestamp":1723425737,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月9日收盘，凯莱英报收于70.56元，下跌3.09%，换手率1.48%，成交量4.86万手，成交额3.47亿元。近5日资金流向一览见下表：凯莱英融资融券信息显示，融资方面，当日融资买入2479.26万元，融资偿还2651.18万元，融资净偿还171.92万元。凯莱英主营业务：是一家全球领先、技术驱动型的医药外包服务一站式综合服务商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200002628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002821","06821","BK0239","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2456437897","title":"凯莱英(06821.HK)累计回购1,230万股A股 涉资10亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2456437897","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456437897?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:10","pubTimestamp":1722525000,"startTime":"0","endTime":"0","summary":"凯莱英(06821.HK) 公布，7月31日止，累计回购1,230.07万股A股，占A股总股本3.5976%；每股作价介乎71.65-102元人民币，支付总金额约10亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-01 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220106150437587_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220106150437587_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1368273/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06821","159982","BK0132","399300","002821","BK0239","BK1191","LU1328615791.USD"],"gpt_icon":0},{"id":"2456109863","title":"【凯莱英(06821.HK)截至7月末累计回购公司A股股份数量为1230.07万股】智通财经APP讯，凯莱英(06821.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456109863","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456109863?lang=zh_cn&edition=full","pubTime":"2024-08-01 18:08","pubTimestamp":1722506931,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1328615791.USD","BK0132","399300","BK0239","BK1191","159982","002821","161027","06821"],"gpt_icon":0},{"id":"2456108615","title":"凯莱英(002821.SZ)已累计回购3.5976%股份 耗资约10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456108615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456108615?lang=zh_cn&edition=full","pubTime":"2024-08-01 17:20","pubTimestamp":1722504039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(002821.SZ)发布公告，截至2024年7月31日，公司累计通过回购专用证券账户以集中竞价方式回购公司股份数量为1230.07万股，占公司A股总股本的3.5976%，最高成交价为102.00元/股，最低成交价为71.65元/股，合计支付的总金额为10亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","LU1328615791.USD","06821","BK1191","BK0239"],"gpt_icon":0},{"id":"2455318911","title":"凯莱英：尊敬的投资，有关公司各成熟和新兴业务板块经营情况已在定期报告中进行过详细披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2455318911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455318911?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:01","pubTimestamp":1722423666,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英07月31日在投资者关系平台上答复投资者关心的问题。有关公司各成熟和新兴业务板块经营情况已在定期报告中进行过详细披露。同时,公司董事会近期审议了《反腐败及反贿赂政策》，并由审计委员会和审计部负责监督及处理日常具体工作，形成合规运营的有力体系保障。详细内容请查阅公司7月27日于巨潮网披露相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100039562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","LU1328615791.USD","BK0132","BK0239","BK1191","002821"],"gpt_icon":0},{"id":"2455941412","title":"凯莱英(06821)上涨5.19%，报46.65元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455941412","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455941412?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:24","pubTimestamp":1722392654,"startTime":"0","endTime":"0","summary":"7月31日，凯莱英(06821)盘中上涨5.19%，截至10:24，报46.65元/股，成交480.04万元。凯莱英医药集团是一家全球领先的CDMO公司，主要为全球新药提供从临床早期到商业化阶段的一站式研发、生产服务，包括高级中间体、原料药、制剂的研发和cGMP生产，以及临床研究服务。公司通过持续技术创新和战略合作，为国内外制药公司、生物技术公司提供药品全生命周期一站式CMC服务，加快新药开发及应用，逐步构建起创新药一体化服务生态圈。截至2024年一季报，凯莱英营业总收入13.64亿元、净利润2.82亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/31102441920630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06821","BK0132","BK0239","002821","BK1191","LU1328615791.USD"],"gpt_icon":0},{"id":"2455946197","title":"【港股异动 | CRO概念股早盘走高 药明康德季度净利润环比增长 康龙化成新签订单金额实现两位数增长】智通财经APP获悉，CRO概念股早盘走高，截至发稿，药明生物(02269.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455946197","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455946197?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:05","pubTimestamp":1722391536,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06821","LU2045819591.USD","LU0856984785.SGD","02359","BK1610","BK1191","LU0516422440.USD","LU1242518931.SGD","LU0039217434.USD","BK1583","LU2125910500.SGD","BK1576","LU0359202008.SGD","LU1242518857.USD","LU2039709279.SGD","LU0456827905.SGD","LU0326950275.SGD","IE00B0JY6N72.USD","002821","LU1688375341.USD","BK0132","LU0456846285.SGD","LU0516423091.SGD","LU0516423174.USD","LU2242644610.SGD","LU1328615791.USD","LU0516422952.EUR","LU0348735423.USD","LU0823426308.USD","03759","LU0327786744.USD","300759","LU0348825331.USD","LU0819121731.USD","SG9999002562.SGD","LU0572944931.SGD","LU1046422090.SGD","02269","LU0588546209.SGD","LU0456842615.SGD","LU0417516902.SGD","LU0516422366.SGD","LU1720050803.USD","603259","LU0043850808.USD","LU0140636845.USD","LU0708995583.HKD","LU1880383366.USD","LU0823426480.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2455629104","title":"【港股异动 | CRO概念股多数走高 药明康德(02359.HK)上半年业绩符合预期 在手订单首超400亿】智通财经APP获悉，CRO概念股多数走高，截至发稿，药明康德(02359.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455629104","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455629104?lang=zh_cn&edition=full","pubTime":"2024-07-30 10:37","pubTimestamp":1722307038,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1880383366.USD","03759","LU1328615791.USD","LU2125910500.SGD","01873","LU1242518931.SGD","LU1242518857.USD","LU2242644610.SGD","IE00B0JY6N72.USD","LU0327786744.USD","LU0307460666.USD","LU0516423091.SGD","LU0572944931.SGD","06821","LU0140636845.USD","LU0516422952.EUR","LU0588546209.SGD","LU0708995583.HKD","LU0456842615.SGD","LU0516422440.USD","LU0856984785.SGD","LU0359202008.SGD","LU0456827905.SGD","300759","LU0348825331.USD","02359","BK1141","LU2045819591.USD","SG9999002562.SGD","LU0359201612.USD","LU0417516902.SGD","LU0823426480.USD","LU1997245177.USD","LU0417516738.SGD","LU0516422366.SGD","LU0819121731.USD","LU0456846285.SGD","LU1046422090.SGD","BK1589","LU0043850808.USD","LU1720050803.USD","BK1583","002821","LU1688375341.USD","BK1610","603259","LU0326950275.SGD","LU2039709279.SGD","LU0039217434.USD","02269"],"gpt_icon":0},{"id":"2455658925","title":"摩根大通减持凯莱英(06821)约17.61万股 每股作价约44.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455658925","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455658925?lang=zh_cn&edition=full","pubTime":"2024-07-29 17:58","pubTimestamp":1722247080,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，7月24日，摩根大通减持凯莱英(06821)17.6128万股，每股作价44.7471港元，总金额约为788.12万港元。减持后最新持股数目为314.3144万股，最新持股比例为11.40%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-29/doc-incfuzva5729617.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-29/doc-incfuzva5729617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1363072403.SGD","BK4585","BK4207","LU0417517546.SGD","IE0034235188.USD","LU1668664300.SGD","LU1267930490.SGD","LU0234572021.USD","LU1244550221.USD","IE00BWXC8680.SGD","06821","IE00BLSP4452.SGD","BK4581","LU0211328371.USD","IE00BZ1G4Q59.USD","BK4550","LU","LU0208291251.USD","LU0496365809.HKD","LU0882574139.USD","LU0976567544.SGD","IE00BJTD4V19.USD","LU1670627923.USD","BK4516","002821","BK4566","LU0070302665.USD","LU1084165304.USD","LU1119994496.HKD","IE00BFXG1179.USD","LU1496350171.SGD","LU0149725797.USD","LU1328615791.USD","LU1496350502.SGD","BK0132","LU1162221912.USD","BK4588","LU1244550577.SGD","LU1670628061.USD","LU1244550494.USD","LU0238689110.USD","LU0310799852.SGD","IE00B775SV38.USD","IE00BKVL7J92.USD","LU0170899867.USD","LU0971096721.USD","LU1032466523.USD","BK1191","LU0320765489.SGD","BK4504"],"gpt_icon":0},{"id":"2455508176","title":"凯莱英（002821）7月26日主力资金净卖出202.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455508176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455508176?lang=zh_cn&edition=full","pubTime":"2024-07-29 09:50","pubTimestamp":1722217852,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月26日收盘，凯莱英报收于67.61元，下跌0.35%，换手率0.77%，成交量2.53万手，成交额1.72亿元。近5日资金流向一览见下表：凯莱英融资融券信息显示，融资方面，当日融资买入1105.02万元，融资偿还1182.1万元，融资净偿还77.08万元。凯莱英主营业务：是一家全球领先、技术驱动型的医药外包服务一站式综合服务商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900004036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","06821","LU1328615791.USD","002821","BK1191","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","stockEarnings":[{"period":"1week","weight":-0.0973},{"period":"1month","weight":-0.095},{"period":"3month","weight":-0.2008},{"period":"6month","weight":-0.3613},{"period":"1year","weight":-0.5109},{"period":"ytd","weight":-0.4679}],"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"36771万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 凯莱英医药集团(天津)股份有限公司是一家全球领先的服务于新药研发和生产的CDMO一站式综合服务商。为国内外大中型制药企业、生物技术公司提供高效和高质量的研发与生产服务，助推创新药的临床研究与商业化应用。主要包括临床阶段药品、商业化阶段药品、技术服务。公司是全球第五大创新药原料药CDMO公司，约占据1.5%的市场份额（第一名市场份额约为2.9%）；是中国最大的商业化阶段化学药物CDMO公司，约占据22%的市场份额。","serverTime":1724604231481,"listedPrice":30.53,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}